Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis.
about
Dysbiosis in inflammatory bowel diseaseUse of Biologics in Pouchitis: A Systematic ReviewReal-time analysis of mucosal flora in patients with inflammatory bowel disease in India.Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.Diversity and distribution of sulphate-reducing bacteria in human faeces from healthy subjects and patients with inflammatory bowel disease.Pouchitis.IBD-what role do Proteobacteria play?The bowel microbiota and inflammatory bowel diseases.Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis.The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis.Effect of liquiritin on human intestinal bacteria growth: metabolism and modulation.Influences of the colonic microbiome on the mucous gel layer in ulcerative colitisFrequency and risk factors of low immunoglobulin levels in patients with inflammatory bowel disease.Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole.Clinical approach to diseases of ileal pouch-anal anastomosis.Microbial pathways in colonic sulfur metabolism and links with health and disease.Systematic review: the management of pouchitis.From biocontrol to cancer, probiotics and beyondAnalysis of bacterial bowel communities of IBD patients: what has it revealed?Real-time molecular monitoring of chemical environment in obligate anaerobes during oxygen adaptive responseLaboratory tests for patients with ileal pouch-anal anastomosis: clinical utility in predicting, diagnosing, and monitoring pouch disorders.Pros and cons of antibiotic therapy for pouchitis.The bacterial pathogenesis and treatment of pouchitis.Etiology of pouchitis.Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.Contributions of the microbial hydrogen economy to colonic homeostasis.Bacteriology in the etiopathogenesis of pouchitis.Hydrogen sulfide signaling in the gastrointestinal tract.Role of intestinal bacteria in the pathogenesis of pouchitis.Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel.Review article: the pathogenesis of pouchitis.Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: Diagnosis, management, risk factors, and incidence.Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.Host-microbial Cross-talk in Inflammatory Bowel Disease.A shift from colon- to ileum-predominant bacteria in ileal-pouch feces following total proctocolectomy.Update on the pathogenesis and management of pouchitis.Inflammatory pouch disease: The spectrum of pouchitis.Chronic use of PPI and H2 antagonists decreases the risk of pouchitis after IPAA for ulcerative colitis.Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis.Systematic review: ileoanal pouch microbiota in health and disease.
P2860
Q24685931-045B0BDA-9EB8-46B5-BD0C-BCAF7D76A39EQ26995117-29B7F146-4773-4EB1-8628-5C8ABD4D02B5Q33699653-7B989BA1-1D7B-4C09-AF6C-DCF1693302C3Q34008761-039C793F-7D6D-46E1-ABA2-B1131FC64EB4Q34151794-8D80AC26-7FCC-4812-9871-133A019FB24EQ34233134-D6F91554-B6AF-45BA-83C1-CCBBB10F1D49Q34255700-9590FF18-3615-47BC-B46C-7F0997DB6ECDQ34415209-58CD4433-6B63-4532-8A0A-E75A3CBD7ECCQ34801289-9C756B69-6D3F-486B-A000-74579743DA5AQ34955775-E4C6F22D-2691-4931-8A49-D1463C3D5F76Q35116901-79A0246D-1040-48F7-90C7-598252F092E1Q35142966-CDE40C6E-E563-4C6D-B415-2C9D9DF409C9Q35580140-24B82944-850B-469B-A6A2-11F81874FE58Q35597016-5BF9B490-EED7-4C20-9FB6-BCDD26C809E3Q36360514-C4917013-B787-4F56-9C07-58F4FE8BA3BFQ36429327-E726DE4C-F6F3-4332-B0F9-4590E062D3DAQ36447568-70C18E4F-785B-4455-AAC2-79660C09ADD6Q37057140-89758F9E-DCAE-4C8D-994D-7B66E9DC849FQ37084765-9C38EEDE-6453-40ED-AA69-DDC29E615640Q37229258-288BF14B-B52D-499C-810D-0D4C723FEDFCQ37551596-DE5CFE3F-82FB-4E52-BE78-FAE4CF261F38Q37611860-1801DA45-B2EB-4829-9343-7361F77B377DQ37823330-A30C9C96-8986-4308-92A2-5E42BC6764E1Q37948714-F4BFFC60-7068-4C10-836C-533BBBE29016Q38003046-E29CB15F-4220-48EE-8790-D62E157F54D8Q38010069-3D4076C2-6E84-491B-A0DF-DEDE4F75459CQ38026393-E01E0631-988B-4209-A4E5-BB798FB97F52Q38098623-D050F55C-1225-4A42-803A-4D5FE51EAC56Q38232120-E2C594BD-469D-4B92-87FD-9DC762905007Q38810502-0D89A946-21B3-4C4A-A2EA-E395208224B5Q38828436-4E2628F9-D1B6-4422-95C2-6EAA88D6225EQ38966995-BD7CB57C-EA00-4EAF-9A00-0DF8D4D9BA4DQ39007371-E872EE54-41DB-4F76-AD71-6A76D391CFE5Q39162452-E8F483AB-E032-4255-ADF5-393D129E0BD5Q39624261-467F8749-FACB-475D-B652-33A242A67F5CQ41687297-806F557E-77FB-44F0-BBC7-9C6CE6056E76Q42425137-EA3907FD-5318-4B38-8482-02EE1AD95E4CQ44251263-97ABE40B-EDE1-4A7E-A418-60BF5C66CADFQ45019303-5F536B3E-9584-49C5-A63C-76AC7CEBBF9EQ46247978-B02A729C-F749-4629-BE01-44AC56A1DF45
P2860
Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Sulfate-reducing bacteria colo ...... amilial adenomatous polyposis.
@en
Sulfate-reducing bacteria colo ...... amilial adenomatous polyposis.
@nl
type
label
Sulfate-reducing bacteria colo ...... amilial adenomatous polyposis.
@en
Sulfate-reducing bacteria colo ...... amilial adenomatous polyposis.
@nl
prefLabel
Sulfate-reducing bacteria colo ...... amilial adenomatous polyposis.
@en
Sulfate-reducing bacteria colo ...... amilial adenomatous polyposis.
@nl
P2093
P1476
Sulfate-reducing bacteria colo ...... amilial adenomatous polyposis.
@en
P2093
P2888
P304
P356
10.1007/S10350-004-6187-Z
P577
2002-03-01T00:00:00Z